FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2168391791> ?p ?o ?g. }

• W2168391791 endingPage "251" @default.
• W2168391791 startingPage "242" @default.
• W2168391791 abstract "Adipokines derived from adipocytes are important factors that act as circulating regulators of bone metabolism. C1q/tumor necrosis factor (TNF)-related Protein-3 (CTRP3) is a novel adipokine with multiple effects such as lowering glucose levels, inhibiting gluconeogenesis in the liver, and increasing angiogenesis and anti-inflammation. However, the effects and the mechanisms of CTRP3 on bone metabolism, which is regulated by osteoblasts and osteoclasts, have not been investigated. Here, we found that CTRP3 inhibited osteoclast differentiation induced by osteoclastogenic factors in bone marrow cell-osteoblast co-cultures, but did not affect the ratio of receptor activator of nuclear factor κB (NF-κB) ligand (RANKL) to osteoprotegerin (OPG) induced by osteoclastogenic factors in osteoblasts. We also found that CTRP3 inhibited osteoclast differentiation from mouse bone marrow macrophages (BMMs) induced by RANKL in a dose-dependent manner without cytotoxicity. Functionally, CTRP3 inhibited the F-actin formation and bone resorbing activity of mature osteoclasts. Pretreatment with CTRP3 significantly inhibited RANKL-induced expression of c-Fos and nuclear factor of activated T-cells (NFATc1), essential transcription factors for osteoclast development. Surprisingly, the activation of AMP-activated protein kinase (AMPK) was considerably increased by pretreatment with CTRP3 for 1h. The CTRP3-stimulated AMPK activation was also maintained during RANKL-induced osteoclastogenesis. CTRP3 did not affect RANKL-induced p38, ERK, JNK, Akt, IκB, CREB, and calcium signaling (Btk and PLCγ2). These results suggest that CTRP3 plays an important role as a negative regulator of RANKL-mediated osteoclast differentiation by acting as an inhibitor of NFATc1 activation through the AMPK signaling pathway. Furthermore, CTRP3 treatment reduced RANKL-induced osteoclast formation and bone destruction in mouse calvarial bone in vivo based on micro-CT and histologic analysis. In conclusion, these findings strongly suggest that CTRP3 deserves new evaluation as a potential treatment target in various bone diseases associated with excessive osteoclast differentiation and bone destruction." @default.
• W2168391791 created "2016-06-24" @default.
• W2168391791 creator A5006515436 @default.
• W2168391791 creator A5011243332 @default.
• W2168391791 creator A5013166947 @default.
• W2168391791 creator A5023390210 @default.
• W2168391791 creator A5027370880 @default.
• W2168391791 creator A5037611086 @default.
• W2168391791 creator A5043954879 @default.
• W2168391791 creator A5080728919 @default.
• W2168391791 creator A5088705978 @default.
• W2168391791 date "2015-10-01" @default.
• W2168391791 modified "2023-10-18" @default.
• W2168391791 title "CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo" @default.
• W2168391791 cites W1847131470 @default.
• W2168391791 cites W1964066819 @default.
• W2168391791 cites W1965404141 @default.
• W2168391791 cites W1972001482 @default.
• W2168391791 cites W1989343687 @default.
• W2168391791 cites W1990079419 @default.
• W2168391791 cites W1998038829 @default.
• W2168391791 cites W1999716846 @default.
• W2168391791 cites W2002315265 @default.
• W2168391791 cites W2005794914 @default.
• W2168391791 cites W2008654911 @default.
• W2168391791 cites W2010562302 @default.
• W2168391791 cites W2020087564 @default.
• W2168391791 cites W2025056866 @default.
• W2168391791 cites W2025327530 @default.
• W2168391791 cites W2037499635 @default.
• W2168391791 cites W2037680067 @default.
• W2168391791 cites W2038397489 @default.
• W2168391791 cites W2050182686 @default.
• W2168391791 cites W2057859960 @default.
• W2168391791 cites W2063513932 @default.
• W2168391791 cites W2075602092 @default.
• W2168391791 cites W2077372396 @default.
• W2168391791 cites W2079270852 @default.
• W2168391791 cites W2079678117 @default.
• W2168391791 cites W2092268043 @default.
• W2168391791 cites W2093252878 @default.
• W2168391791 cites W2096225770 @default.
• W2168391791 cites W2098085126 @default.
• W2168391791 cites W2108565331 @default.
• W2168391791 cites W2123993322 @default.
• W2168391791 cites W2129318162 @default.
• W2168391791 cites W2135424721 @default.
• W2168391791 cites W2136857252 @default.
• W2168391791 cites W2151966001 @default.
• W2168391791 cites W2161455288 @default.
• W2168391791 cites W2165511735 @default.
• W2168391791 cites W2172061231 @default.
• W2168391791 doi "https://doi.org/10.1016/j.bone.2015.06.011" @default.
• W2168391791 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26103094" @default.
• W2168391791 hasPublicationYear "2015" @default.
• W2168391791 type Work @default.
• W2168391791 sameAs 2168391791 @default.
• W2168391791 citedByCount "33" @default.
• W2168391791 countsByYear W21683917912016 @default.
• W2168391791 countsByYear W21683917912017 @default.
• W2168391791 countsByYear W21683917912018 @default.
• W2168391791 countsByYear W21683917912019 @default.
• W2168391791 countsByYear W21683917912020 @default.
• W2168391791 countsByYear W21683917912021 @default.
• W2168391791 countsByYear W21683917912022 @default.
• W2168391791 crossrefType "journal-article" @default.
• W2168391791 hasAuthorship W2168391791A5006515436 @default.
• W2168391791 hasAuthorship W2168391791A5011243332 @default.
• W2168391791 hasAuthorship W2168391791A5013166947 @default.
• W2168391791 hasAuthorship W2168391791A5023390210 @default.
• W2168391791 hasAuthorship W2168391791A5027370880 @default.
• W2168391791 hasAuthorship W2168391791A5037611086 @default.
• W2168391791 hasAuthorship W2168391791A5043954879 @default.
• W2168391791 hasAuthorship W2168391791A5080728919 @default.
• W2168391791 hasAuthorship W2168391791A5088705978 @default.
• W2168391791 hasConcept C11960822 @default.
• W2168391791 hasConcept C126322002 @default.
• W2168391791 hasConcept C134018914 @default.
• W2168391791 hasConcept C170033053 @default.
• W2168391791 hasConcept C170493617 @default.
• W2168391791 hasConcept C185592680 @default.
• W2168391791 hasConcept C202751555 @default.
• W2168391791 hasConcept C2776033226 @default.
• W2168391791 hasConcept C2778260815 @default.
• W2168391791 hasConcept C2779428903 @default.
• W2168391791 hasConcept C2780124434 @default.
• W2168391791 hasConcept C2780426850 @default.
• W2168391791 hasConcept C2909639871 @default.
• W2168391791 hasConcept C55493867 @default.
• W2168391791 hasConcept C71924100 @default.
• W2168391791 hasConcept C86803240 @default.
• W2168391791 hasConcept C88045685 @default.
• W2168391791 hasConcept C95444343 @default.
• W2168391791 hasConcept C97029542 @default.
• W2168391791 hasConceptScore W2168391791C11960822 @default.
• W2168391791 hasConceptScore W2168391791C126322002 @default.
• W2168391791 hasConceptScore W2168391791C134018914 @default.
• W2168391791 hasConceptScore W2168391791C170033053 @default.

• next